-
2
-
-
68549099879
-
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005
-
Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115:3801-7.
-
(2009)
Cancer
, vol.115
, pp. 3801-3807
-
-
Chen, A.Y.1
Jemal, A.2
Ward, E.M.3
-
3
-
-
84899584354
-
Current thyroid cancer trends in the United States
-
Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014; 140:317-22.
-
(2014)
JAMA Otolaryngol Head Neck Surg
, vol.140
, pp. 317-322
-
-
Davies, L.1
Welch, H.G.2
-
4
-
-
84879126781
-
Cancer statistics in Korea: Incidence, mortality, survival and prevalence in 2010
-
Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14.
-
(2013)
Cancer Res Treat
, vol.45
, pp. 1-14
-
-
Jung, K.W.1
Won, Y.J.2
Kong, H.J.3
Oh, C.M.4
Seo, H.G.5
Lee, J.S.6
-
5
-
-
77955795965
-
Trends analysis of characteristics of thyroid cancer patients in one medical center
-
Lee SH, Kim T, Y, Ryu JS, Gong G, Kim WB, Kim SC, Hong SJ, Shong YK. Trends analysis of characteristics of thyroid cancer patients in one medical center. J Korean Endocr Soc 2008;23:35-43.
-
(2008)
J Korean Endocr Soc
, vol.23
, pp. 35-43
-
-
Lee, S.H.1
Kim, T.Y.2
Ryu, J.S.3
Gong, G.4
Kim, W.B.5
Kim, S.C.6
Hong, S.J.7
Shong, Y.K.8
-
6
-
-
84880007599
-
The clinical and economic burden of a sustained increase in thyroid cancer incidence
-
Aschebrook-Kilfoy B, Schechter RB, Shih YC, Kaplan EL, Chiu BC, Angelos P, Grogan RH. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev 2013;22:1252-9.
-
(2013)
Cancer Epidemiol Biomarkers Prev
, vol.22
, pp. 1252-1259
-
-
Aschebrook-Kilfoy, B.1
Schechter, R.B.2
Shih, Y.C.3
Kaplan, E.L.4
Chiu, B.C.5
Angelos, P.6
Grogan, R.H.7
-
7
-
-
84877710930
-
Follicular thyroid cancer incidence patterns in the United States, 1980-2009
-
Aschebrook-Kilfoy B, Grogan RH, Ward MH, Kaplan E, Devesa SS. Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid 2013;23:1015-21.
-
(2013)
Thyroid
, vol.23
, pp. 1015-1021
-
-
Aschebrook-Kilfoy, B.1
Grogan, R.H.2
Ward, M.H.3
Kaplan, E.4
Devesa, S.S.5
-
8
-
-
84901505961
-
Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: A population-based study
-
Vergamini LB, Frazier AL, Abrantes FL, Ribeiro KB, Rodriguez-Galindo C. Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. J Pediatr 2014;164:1481-5.
-
(2014)
J Pediatr
, vol.164
, pp. 1481-1485
-
-
Vergamini, L.B.1
Frazier, A.L.2
Abrantes, F.L.3
Ribeiro, K.B.4
Rodriguez-Galindo, C.5
-
9
-
-
84880507665
-
Mutational heterogeneity in cancer and the search for new cancer-associated genes
-
Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, Kiezun A, Hammerman PS, McKenna A, Drier Y, Zou L, Ramos AH, Pugh TJ, Stransky N, Helman E, Kim J, Sougnez C, Ambrogio L, Nickerson E, Shefler E, Cortes ML, Auclair D, Saksena G, Voet D, Noble M, DiCara D, Lin P, Lichtenstein L, Heiman DI, Fennell T, Imielinski M, Hernandez B, Hodis E, Baca S, Dulak AM, Lohr J, Landau DA, Wu CJ, Melendez-Zajgla J, Hidalgo-Miranda A, Koren A, McCarroll SA, Mora J, Lee RS, Crompton B, Onofrio R, Parkin M, Winckler W, Ardlie K, Gabriel SB, Roberts CW, Biegel JA, Stegmaier K, Bass AJ, Garraway LA, Meyerson M, Golub TR, Gordenin DA, Sunyaev S, Lander ES, Getz G. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013;499: 214-8.
-
(2013)
Nature
, vol.499
, pp. 214-218
-
-
Lawrence, M.S.1
Stojanov, P.2
Polak, P.3
Kryukov, G.V.4
Cibulskis, K.5
Sivachenko, A.6
Carter, S.L.7
Stewart, C.8
Mermel, C.H.9
Roberts, S.A.10
Kiezun, A.11
Hammerman, P.S.12
McKenna, A.13
Drier, Y.14
Zou, L.15
Ramos, A.H.16
Pugh, T.J.17
Stransky, N.18
Helman, E.19
Kim, J.20
Sougnez, C.21
Ambrogio, L.22
Nickerson, E.23
Shefler, E.24
Cortes, M.L.25
Auclair, D.26
Saksena, G.27
Voet, D.28
Noble, M.29
DiCara, D.30
Lin, P.31
Lichtenstein, L.32
Heiman, D.I.33
Fennell, T.34
Imielinski, M.35
Hernandez, B.36
Hodis, E.37
Baca, S.38
Dulak, A.M.39
Lohr, J.40
Landau, D.A.41
Wu, C.J.42
Melendez-Zajgla, J.43
Hidalgo-Miranda, A.44
Koren, A.45
McCarroll, S.A.46
Mora, J.47
Lee, R.S.48
Crompton, B.49
Onofrio, R.50
Parkin, M.51
Winckler, W.52
Ardlie, K.53
Gabriel, S.B.54
Roberts, C.W.55
Biegel, J.A.56
Stegmaier, K.57
Bass, A.J.58
Garraway, L.A.59
Meyerson, M.60
Golub, T.R.61
Gordenin, D.A.62
Sunyaev, S.63
Lander, E.S.64
Getz, G.65
more..
-
10
-
-
66849099347
-
Minimal oxidative load: A prerequisite for thyroid cell function
-
Poncin S, Colin IM, Gerard AC. Minimal oxidative load: a prerequisite for thyroid cell function. J Endocrinol 2009; 201:161-7.
-
(2009)
J Endocrinol
, vol.201
, pp. 161-167
-
-
Poncin, S.1
Colin, I.M.2
Gerard, A.C.3
-
11
-
-
84888130909
-
Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress
-
Melis JP, Kuiper RV, Zwart E, Robinson J, Pennings JL, van Oostrom CT, Luijten M, van Steeg H. Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress. DNA Repair (Amst) 2013;12:1081-6.
-
(2013)
DNA Repair (Amst)
, vol.12
, pp. 1081-1086
-
-
Melis, J.P.1
Kuiper, R.V.2
Zwart, E.3
Robinson, J.4
Pennings, J.L.5
van Oostrom, C.T.6
Luijten, M.7
van Steeg, H.8
-
12
-
-
84862909031
-
Total oxidant/antioxidant status in sera of patients with thyroid cancers
-
Wang D, Feng JF, Zeng P, Yang YH, Luo J, Yang YW. Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr Relat Cancer 2011;18:773-82.
-
(2011)
Endocr Relat Cancer
, vol.18
, pp. 773-782
-
-
Wang, D.1
Feng, J.F.2
Zeng, P.3
Yang, Y.H.4
Luo, J.5
Yang, Y.W.6
-
14
-
-
84878676922
-
Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population
-
Han JM, Kim TY, Jeon MJ, Yim JH, Kim WG, Song DE, Hong SJ, Bae SJ, Kim HK, Shin MH, Shong YK, Kim WB. Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol 2013; 168:879-86.
-
(2013)
Eur J Endocrinol
, vol.168
, pp. 879-886
-
-
Han, J.M.1
Kim, T.Y.2
Jeon, M.J.3
Yim, J.H.4
Kim, W.G.5
Song, D.E.6
Hong, S.J.7
Bae, S.J.8
Kim, H.K.9
Shin, M.H.10
Shong, Y.K.11
Kim, W.B.12
-
15
-
-
85027830983
-
Lack of associations between body mass index andclinical outcomes in patients with papillary thyroid carcinoma
-
Kwon H, Kim M, Choi YM, Jang EK, Jeon MJ, Kim WG, Kim TY, Shong YK, Song DE, Baek JH, Hong SJ, Kim WB. Lack of associations between body mass index andclinical outcomes in patients with papillary thyroid carcinoma. Endocrinol Metab (Seoul) 2014;29:e54.
-
(2014)
Endocrinol Metab (Seoul)
, vol.29
, pp. e54
-
-
Kwon, H.1
Kim, M.2
Choi, Y.M.3
Jang, E.K.4
Jeon, M.J.5
Kim, W.G.6
Kim, T.Y.7
Shong, Y.K.8
Song, D.E.9
Baek, J.H.10
Hong, S.J.11
Kim, W.B.12
-
16
-
-
84863961382
-
Basal STAT3 activities are negatively correlated with tumor size in papillary thyroid carcinomas
-
Kim WG, Choi HJ, Kim WB, Kim EY, Yim JH, Kim TY, Gong G, Kim SY, Chung N, Shong YK. Basal STAT3 activities are negatively correlated with tumor size in papillary thyroid carcinomas. J Endocrinol Invest 2012;35:413-8.
-
(2012)
J Endocrinol Invest
, vol.35
, pp. 413-418
-
-
Kim, W.G.1
Choi, H.J.2
Kim, W.B.3
Kim, E.Y.4
Yim, J.H.5
Kim, T.Y.6
Gong, G.7
Kim, S.Y.8
Chung, N.9
Shong, Y.K.10
-
17
-
-
84999440299
-
Prognostic factors correlated with cancer specific survival and disease-free survival of papillary thyroid carcinoma in Korea
-
Kim WG, Kim WB, Kim TY, Kim EY, Ryu JS, Gong G, Lee JH, Yoon JH, Kim JM, Hong SJ, Shong YK. Prognostic factors correlated with cancer specific survival and disease-free survival of papillary thyroid carcinoma in Korea. J Korean Thyroid Assoc 2008;1:17-23.
-
(2008)
J Korean Thyroid Assoc
, vol.1
, pp. 17-23
-
-
Kim, W.G.1
Kim, W.B.2
Kim, T.Y.3
Kim, E.Y.4
Ryu, J.S.5
Gong, G.6
Lee, J.H.7
Yoon, J.H.8
Kim, J.M.9
Hong, S.J.10
Shong, Y.K.11
-
18
-
-
84874519679
-
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma
-
Jeon MJ, Yoon JH, Han JM, Yim JH, Hong SJ, Song DE, Ryu JS, Kim TY, Shong YK, Kim WB. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol 2013;168:219-25.
-
(2013)
Eur J Endocrinol
, vol.168
, pp. 219-225
-
-
Jeon, M.J.1
Yoon, J.H.2
Han, J.M.3
Yim, J.H.4
Hong, S.J.5
Song, D.E.6
Ryu, J.S.7
Kim, T.Y.8
Shong, Y.K.9
Kim, W.B.10
-
19
-
-
33747369828
-
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma
-
Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G, Lee S, Kim SY, Kim SC, Hong SJ, Shong YK. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2006;65:364-8.
-
(2006)
Clin Endocrinol (Oxf)
, vol.65
, pp. 364-368
-
-
Kim, T.Y.1
Kim, W.B.2
Rhee, Y.S.3
Song, J.Y.4
Kim, J.M.5
Gong, G.6
Lee, S.7
Kim, S.Y.8
Kim, S.C.9
Hong, S.J.10
Shong, Y.K.11
-
20
-
-
84898465257
-
Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population
-
Yim JH, Kim WG, Jeon MJ, Han JM, Kim TY, Yoon JH, Hong SJ, Song DE, Gong G, Shong YK, Kim WB. Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population. Thyroid 2014; 24:689-94.
-
(2014)
Thyroid
, vol.24
, pp. 689-694
-
-
Yim, J.H.1
Kim, W.G.2
Jeon, M.J.3
Han, J.M.4
Kim, T.Y.5
Yoon, J.H.6
Hong, S.J.7
Song, D.E.8
Gong, G.9
Shong, Y.K.10
Kim, W.B.11
-
21
-
-
69949188304
-
Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma
-
Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2009;71:581-6.
-
(2009)
Clin Endocrinol (Oxf)
, vol.71
, pp. 581-586
-
-
Kim, E.Y.1
Kim, W.G.2
Kim, W.B.3
Kim, T.Y.4
Kim, J.M.5
Ryu, J.S.6
Hong, S.J.7
Gong, G.8
Shong, Y.K.9
-
22
-
-
84908067221
-
Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma
-
Jeon MJ, Kim TY, Kim WG, Han JM, Jang EK, Choi YM, Song DE, Yoon JH, Chung KW, Hong SJ, Shong YK, Kim WB. Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2014;81:593-9.
-
(2014)
Clin Endocrinol (Oxf)
, vol.81
, pp. 593-599
-
-
Jeon, M.J.1
Kim, T.Y.2
Kim, W.G.3
Han, J.M.4
Jang, E.K.5
Choi, Y.M.6
Song, D.E.7
Yoon, J.H.8
Chung, K.W.9
Hong, S.J.10
Shong, Y.K.11
Kim, W.B.12
-
23
-
-
84926468747
-
Current status and future perspectives in differentiated thyroid cancer
-
Kim TY, Kim WG, Kim WB, Shong YK. Current status and future perspectives in differentiated thyroid cancer. Endocrinol Metab (Seoul) 2014;29:217-25.
-
(2014)
Endocrinol Metab (Seoul)
, vol.29
, pp. 217-225
-
-
Kim, T.Y.1
Kim, W.G.2
Kim, W.B.3
Shong, Y.K.4
-
24
-
-
57349163504
-
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma
-
Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Ryu JS, Gong G, Hong SJ, Shong YK. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 2008;93:4683-9.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 4683-4689
-
-
Kim, W.G.1
Yoon, J.H.2
Kim, W.B.3
Kim, T.Y.4
Kim, E.Y.5
Kim, J.M.6
Ryu, J.S.7
Gong, G.8
Hong, S.J.9
Shong, Y.K.10
-
25
-
-
84864700771
-
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment
-
Han JM, Kim WB, Yim JH, Kim WG, Kim TY, Ryu JS, Gong G, Sung TY, Yoon JH, Hong SJ, Kim EY, Shong YK. Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment. Thyroid 2012;22:784-90.
-
(2012)
Thyroid
, vol.22
, pp. 784-790
-
-
Han, J.M.1
Kim, W.B.2
Yim, J.H.3
Kim, W.G.4
Kim, T.Y.5
Ryu, J.S.6
Gong, G.7
Sung, T.Y.8
Yoon, J.H.9
Hong, S.J.10
Kim, E.Y.11
Shong, Y.K.12
-
26
-
-
84872054345
-
Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer
-
Yim JH, Kim EY, Bae Kim W, Kim WG, Kim TY, Ryu JS, Gong G, Hong SJ, Yoon JH, Shong YK. Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer. Thyroid 2013;23:58-63.
-
(2013)
Thyroid
, vol.23
, pp. 58-63
-
-
Yim, J.H.1
Kim, E.Y.2
Bae Kim, W.3
Kim, W.G.4
Kim, T.Y.5
Ryu, J.S.6
Gong, G.7
Hong, S.J.8
Yoon, J.H.9
Shong, Y.K.10
-
27
-
-
77749267572
-
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan
-
Kim WG, Ryu JS, Kim EY, Lee JH, Baek JH, Yoon JH, Hong SJ, Kim ES, Kim TY, Kim WB, Shong YK. Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan. J Clin Endocrinol Metab 2010;95:1169-73.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 1169-1173
-
-
Kim, W.G.1
Ryu, J.S.2
Kim, E.Y.3
Lee, J.H.4
Baek, J.H.5
Yoon, J.H.6
Hong, S.J.7
Kim, E.S.8
Kim, T.Y.9
Kim, W.B.10
Shong, Y.K.11
-
28
-
-
79960087723
-
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation
-
Yim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, Gong G, Hong SJ, Shong YK. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab 2011;96:2049-56.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 2049-2056
-
-
Yim, J.H.1
Kim, W.B.2
Kim, E.Y.3
Kim, W.G.4
Kim, T.Y.5
Ryu, J.S.6
Gong, G.7
Hong, S.J.8
Shong, Y.K.9
-
29
-
-
83155177212
-
Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation
-
Yim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, Moon DH, Sung TY, Yoon JH, Kim SC, Hong SJ, Shong YK. Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation. J Clin Endocrinol Metab 2011;96:3695-700.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 3695-3700
-
-
Yim, J.H.1
Kim, W.B.2
Kim, E.Y.3
Kim, W.G.4
Kim, T.Y.5
Ryu, J.S.6
Moon, D.H.7
Sung, T.Y.8
Yoon, J.H.9
Kim, S.C.10
Hong, S.J.11
Shong, Y.K.12
-
30
-
-
84904855170
-
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: A randomised, double-blind, phase 3 trial
-
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Pena C, Molnar I, Schlumberger MJ; DECISION investigators. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 2014;384:319-28.
-
(2014)
Lancet
, vol.384
, pp. 319-328
-
-
Brose, M.S.1
Nutting, C.M.2
Jarzab, B.3
Elisei, R.4
Siena, S.5
Bastholt, L.6
de la Fouchardiere, C.7
Pacini, F.8
Paschke, R.9
Shong, Y.K.10
Sherman, S.I.11
Smit, J.W.12
Chung, J.13
Kappeler, C.14
Pena, C.15
Molnar, I.16
Schlumberger, M.J.17
-
31
-
-
85047657192
-
Cancer Discov
-
Lenvatinib slows progression of thyroid cancer. Cancer Discov 2014;4:OF7.
-
(2014)
, vol.4
, pp. OF7
-
-
|